<p>Supplementary Table S2. Representativeness of Study Participants</p>
<div>AbstractPurpose:<p>Metastatic castration-resistant prostate cancer with homologous recombination (HR) deficiency (HRD) is sensitive to PARP inhibitors (PARPi). ...
<p>Swimmer plot showing treatment duration on study for all patients. Genomic alterations in the homologous recombination DNA repair and PI3K/AKT/mTOR pathways are noted f...
<p>Supplementary Table S1. Dose-escalation Schema</p>
<p>Plasma concentration for copanlisib (BAY 80-6946). Plasma concentration of copanlisib (BAY 80-6946) was measured in samples from nine patients collected on cycle 1 day ...
<p>Baseline patient characteristics.</p>
<p>HRD pathogenic genomic alterations.</p>
h-index: Number of publications with at least h citations each.